Gilead Sciences Inc articles over last 30 days

- articles last 30 days - articles per day
Mentioned in this news Places Companies People
2014/10/25 15:09
2014/10/25 15:09
14h
Drugmaker Bristol-Myers Squibb Co. beat analysts' earnings estimates on better-than-expected sales of several key medicines led by the cancer therapy Yervoy. Third-quarter net income rose 4.2 percent...
2014/10/25 15:09
2014/10/25 15:09
Latest videos
2014/10/24 19:50
2014/10/24 19:50
1d
Despite Third Point, low expectations for Amgen breakup Related Topics (Reuters) - Amgen Inc (AMGN.O), one of the world's largest biotechnology companies, will unveil next week its first strategy...
2014/10/23 11:27
2014/10/23 11:27
2d
Trader disclosure: On Oct. 22, 2014, the following stocks and commodities mentioned or intended to be mentioned on CNBC's "Fast Money" were owned by the "Fast Money" traders: Pete Najarian is long...
2014/10/22 06:46
2014/10/22 06:46
3d
Hepatitis C, a potentially deadly inflammation of the liver, afflicts more than 3.2 million Americans. Around 70 percent of them will develop chronic liver disease, and as many as 5 percent will die...
2014/10/21 21:17
2014/10/21 21:17
4d
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its third quarter 2014 financial results will be released on Tuesday, October 28, at 4:05 p.m. Eastern...
2014/10/19 17:22
2014/10/19 17:22
6d
NEW YORK (AP) — The largest U.S. gay-rights organization Saturday endorsed efforts to promote the use of a once-a-day pill to prevent HIV infection and called on insurers to provide more generous...
2014/10/17 22:17
2014/10/17 22:17
8d
FOSTER CITY, California--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) ha comunicado que Health Canada ha emitido una notificación de conformidad de Harvoni™ (ledipasvir 90 mg/sofosbuvir 400...
2014/10/17 22:17
2014/10/17 22:17
8d
FOSTER CITY, Kalifornien (USA)--(BUSINESS WIRE)--Das Unternehmen Gilead Sciences, Inc. (Nasdaq: GILD) hat heute bekannt gegeben, dass Health Canada eine Notice of Compliance für Harvoni™ (Ledipasvir...
2014/10/17 22:17
2014/10/17 22:17
8d
FOSTER CITY, Californië (VS)--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) kondigde vandaag aan dat Health Canada een Notice of Compliance heeft afgegeven voor Harvoni™ (ledipasvir 90...
2014/10/16 21:45
2014/10/16 21:45
9d
BOSTON: Some of Wall Street’s biggest names are licking their wounds as October lives up to its reputation as one of the market’s roughest months. The Standard & Poor’s 500 index has now lost almost 8...
2014/10/15 16:44
2014/10/15 16:44
10d
... AbbVie Inc. may scrap or renegotiate its planned 32.4-billion-pound ($51.5 billion) deal for Dublin-based drugmaker Shire Plc, in what would be the biggest casualty of the U.S. crackdown...
2014/10/14 23:39
2014/10/14 23:39
11d
If only all of my stocks produced returns like Johnson & Johnson. Since I wrote a favourable column about J&J in October, 2012, shares of the world’s biggest health-care products company have posted...
2014/10/14 21:48
2014/10/14 21:48
11d
NEW YORK (AP) — Stocks that moved substantially or traded heavily Tuesday on the New York Stock Exchange and the Nasdaq Stock Market: Johnson & Johnson, down $2.11 to $97.01 The world’s biggest...
2014/10/14 12:55
2014/10/14 12:55
11d
Johnson & Johnson said its third-quarter earnings rose 26 per cent on higher pharmaceutical sales despite a stronger US dollar and a smaller boost from its Olysio hepatitis C drug that faces new...
2014/10/14 12:49
2014/10/14 12:49
11d
Johnson & Johnson said its third-quarter earnings rose 26% on higher pharmaceutical sales despite a stronger U.S. dollar and a smaller boost from its Olysio hepatitis C drug that faces new competition...
2014/10/10 19:49
2014/10/10 19:49
15d
Gilead’s newly approved hepatitis C drug, Harvoni LOS ANGELES (MarketWatch)—Gilead Sciences Inc. on Friday won regulatory approval for a follow-on medication to its controversial hepatitis C drug...
2014/10/10 18:17
2014/10/10 18:17
15d
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has approved Harvoni® (ledipasvir 90 mg/sofosbuvir 400 mg),...
2014/10/07 15:49
2014/10/07 15:49
18d
Bristol-Myers Squibb Co. said Tuesday it is dropping its efforts to secure approval in the U.S. for a hepatitis C treatment called asunaprevir, a victim of the rapidly changing landscape for treating...
2014/10/06 11:12
2014/10/06 11:12
19d
Published: Monday, 10/6/2014 - Updated: 58 seconds ago Medical roller coaster of hepatis C treatment Barbara Walter, 67, of Fairview, Pa., was cured of hepatitis C. She contracted it from a blood...
2014/10/02 11:06
2014/10/02 11:06
23d
The race to develop a new class of lung-cancer medicines is pitting one of the world’s biggest drugmakers against a five-year-old startup. While Clovis, with 109 employees, is tiny in comparison to...
2014/10/25 15:09
2014/10/25 15:09
Latest from Twitter